---
figid: PMC4594714__bcp0080-0765-f1
figlink: /pmc/articles/PMC4594714/figure/fig01/
number: F1
caption: The RAS-RAF-MEK-ERK pathway and the mechanism of action of vemurafenib, dabrafenib
  and trametinib. Oncogenic mutations in the BRAF protein cause overactivation of
  this pathway, leading to increased cell proliferation, cell survival, and angiogenesis
  (A). Vemurafenib and dabrafenib selectively inhibit mutated BRAF proteins, whereas
  trametinib inhibits MEK and downstream ERK signalling. TF, transcription factor
  (B)
pmcid: PMC4594714
papertitle: Vemurafenib/dabrafenib and trametinib.
reftext: Robert Rissmann, et al. Br J Clin Pharmacol. 2015 Oct;80(4):765-767.
pmc_ranked_result_index: '40661'
pathway_score: 0.9355345
filename: bcp0080-0765-f1.jpg
figtitle: The RAS-RAF-MEK-ERK pathway and the mechanism of action of vemurafenib,
  dabrafenib and trametinib
year: '2015'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4594714__bcp0080-0765-f1.html
  '@type': Dataset
  description: The RAS-RAF-MEK-ERK pathway and the mechanism of action of vemurafenib,
    dabrafenib and trametinib. Oncogenic mutations in the BRAF protein cause overactivation
    of this pathway, leading to increased cell proliferation, cell survival, and angiogenesis
    (A). Vemurafenib and dabrafenib selectively inhibit mutated BRAF proteins, whereas
    trametinib inhibits MEK and downstream ERK signalling. TF, transcription factor
    (B)
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - MAP2K2
  - KRAS
  - NRAS
  - HRAS
  - BRAF
  - TF
  - MAP2K1
  - MAPK3
  - trametinib
  - dabrafenib
  - tyrosine
genes:
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: TF
  symbol: TF
  source: hgnc_symbol
  hgnc_symbol: TF
  entrez: '7018'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
chemicals:
- word: trametinib
  source: MESH
  identifier: C560077
- word: dabrafenib
  source: MESH
  identifier: C561627
- word: tyrosine
  source: MESH
  identifier: D014443
diseases: []
figid_alias: PMC4594714__F1
redirect_from: /figures/PMC4594714__F1
figtype: Figure
---
